We are now in crisis again because of Donald Trump’s executive order freezing aid. Surely local drug manufacture now needs to be implemented without any further delay?

Cipla share price declined 2 percent after the United States Food and Drug Administration (USFDA) has classified the inspection as Voluntary Action Indicated (VAI). At 09:29am, Cipla was quoting ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cipla: The pharma player has informed the exchanges that its manufacturing facility in Bengaluru's Virgonagar has received a Voluntary Action Indicated status from the USFDA. VA Tech Wabag ...

Cipla's stock is priced at Rs 1472.4, reflecting a slight uptick of 0.07% today, with a six-month return of 3.38%. Cipla is currently trading at Rs 1469.15, showing a slight decline of 0.16% today, ...

Shares of Cipla Ltd. fell as much as 2% on Monday after the Mumbai-based drug manufacturer informed the exchanges that its manufacturing facility in Bengaluru's Virgonagar has received a Voluntary ...

Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Solarium Green Energy IPO: Solarium Green Energy’s ₹105.04 crore SME IPO opens on February 6, with shares priced at ₹181-191. Funds will support working capital and corporate expenses. Listing on BSE ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.